Press Releases

 
Press Releases
  Date Title and Summary View
May 29, 2012
San Diego, California – Biocept, Inc., a CLIA-certified laboratory testing company focused on oncology diagnostics, specifically the detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that with collaborators from Columbia University Medical Center and the MD Anderson Cancer Center, it will present three ...
Apr 2, 2012
San Diego, California – Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that it will be presenting three posters at the 103nd Annual Meeting of the American Association for Cancer Research, being held in Chicago Marc...
Feb 20, 2012
San Diego, California – Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that two of its senior scientists, Farideh Bischoff, Ph.D., Vice President of Translational Research, and Lyle Arnold, Ph.D., Senior Vice Presid...
Feb 7, 2012
San Diego and Aliso Viejo, California: – Biocept, Inc., a privately-held laboratory services company focused on Circulating Tumor Cells (CTCs), and Clarient, Inc., a GE Healthcare Company, announced today the US commercial launch of Biocept’s proprietary breast cancer CTC test, OncoCEE-BRTM, which is performed on a blood sample. Onco...
Dec 14, 2011
San Diego, California – Biocept, Inc., a privately?held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells in cancer patients, announced today the publication of a paper on research performed with collaborators from the University of Texas MD Anderson Cancer Center entitled “Novel ...
Nov 15, 2011
San Diego, CA ? Biocept, Inc. today reported that its scientists and academic collaborators will present three posters at the 34th annual San Antonio Breast Cancer Symposium (SABCS) taking place in San Antonio, TX December 6?10, 2011. The poster presentations describe data generated on Biocept’s proprietary OncoCEETM (Oncology Cell Enrichm...
Nov 10, 2011
San Diego, California: ? Biocept, Inc., a privately?held CLIA?certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in blood samples from cancer patients, announced today that the US Patent and Trademark Office has allowed its patent application covering its microchannel capture device deve...
Sep 23, 2011
San Diego, California: – Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced today the publication of a paper describing an analysis of CTC capture using its proprietary Cell Enrichment and Extraction (CEETM) platfor...
Aug 24, 2011
San Diego, California: ? Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in cancer patients, and Clarient, Inc. (a GE Healthcare Company) today announced a collaboration on the commercialization of a proprietary blood test for CTCs in breast cancer...
Jul 28, 2011
Capture, detection and enumeration Determination of HER2/neu status Biocept, Inc., an advanced diagnostic CLIA-certified service laboratory developing novel tests for the oncology community, today announced the availability of OncoCEE-BR™ for breast cancer, a test designed to detect circulating tumor cells (C...
Page: FirstPrevious ...
17
NextLast
= add release to Briefcase